Insider trade

Chair reported a non-open-market transaction in ROIV

Traded Dec 24, 2025 · Filed Dec 30, 2025

Roivant SciencesROIV

65K
Shares · @ $22.47

Why it stands out

Not classified as an open-market trade.

Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell

View the official recordSEC Form 4 — Statement of Changes in Beneficial Ownership

All the details

Dates, kept separate

Transaction date: Dec 24, 2025
Reporting period: Not applicable
Filed with the SEC: Dec 30, 2025

ChairOther

Context

Classification

other

Code J — not an open-market trade

Planned / mechanical clue

None found in footnotes

Only flagged when a footnote says so; never inferred

Source receipt

Record ID: 0001140361-25-046788
Filed / recorded

Dec 30, 2025, 7:00 AM UTC

Added to OQRO

Oct 6, 2026, 8:46 PM UTC

Parser

form4-xml-v2

Data quality

Verified: identifiers matched exactly

Issuer

Roivant Sciences Ltd.

Issuer CIK

1635088

Ticker

ROIV

Reporting person

Frank Torti

Relationship

Officer

Officer title

President and Vant Chair

Security

Common Shares

Table

Non-derivative (Table I)

Transaction date

Dec 24, 2025

Transaction code

J

Shares / units

64,891

Price per share

$22.47

Acquired / disposed

Disposed (D)

Shares owned after

13,847,036

Ownership form

Direct

Amendment

No

Footnotes from the filing

The price reported in column 4 is a weighted average price. These Common Shares were sold in multiple transactions at prices ranging from $22.45 to $22.50, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of Common Shares sold at each separate price within the range.
Represents a sale of Common Shares only to cover estimated taxes due in connection with the exchange described in footnote 1.